Displaying 1 - 12 items out of 12 results
ILCN article
Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC Research
… Circulating Tumor Cell–Derived Patient eXplants: A New Tool for SCLC …
Press release
… services to cancer research. Her research interests span tumor biology, biomarker discovery, preclinical … Biomarker Research program, she became fascinated with circulating tumor cells (CTCs) for use as a liquid biopsy. … proud that some of the earliest work on circulating tumor DNA (ctDNA) done with AstraZeneca and Professor Andrew …
Press release
… complex malignancy. Liquid biopsy, and especially plasma ctDNA, can be used in many clinical settings where tissue is … that IASLC is in the forefront in this arena.” Although tumor tissue is historically the gold standard biospecimen … biopsy approach includes a variety of methodologies for circulating analytes. From a clinical point of view, plasma …
Webinar
… molecular candidates, such as autoantibodies, microRNAs, circulating tumor DNA, blood protein profiling, etc. Other emerging …
Press release
… biology and its evolution over time, using tools like circulating tumour DNA from liquid biopsies, to match patients to the adjuvant … a targeted therapy,” she stated. “The possibility to study circulating tumour cells from blood samples has been a …
Press release
… Award to Gabriella Sozzi, PhD. Dr. Sozzi leads the Tumor Genomics Unit at Fondazione IRCCS Istituto Nazionale Tumori (INT) in Milan, Italy. She graduated in Biological … of lung cancer in screening programs. In the field of circulating biomarkers, she has a demonstrated record of …
Press release
… 2021, 9 a.m. GMT/10 a.m. CDT/11 a.m. EDT) --Pre-treatment circulating tumor (ct)DNA levels more accurately predicted long-term survival than …
Press release
… specific cancer’s growth and progression. Patients whose tumors harbor certain, specific molecular alterations may be … EGFR T790M in relapse may be done by biopsy or cell-free circulating DNA. However cell-free DNA is not appropriate for initial …
Press release
… predictive biomarkers, which may enable better targeting of tumor characteristics. Its aims to accelerate development of … and novel diagnostic approaches – like the detection of circulating tumor DNA in blood samples – to identify patients with a poor …
Landing page
… Pathologist Mary Beth Beasley, MD Apr 26, 2022 Low-Dose CT, ctDNA May Partner for Lung Cancer Detection Leah Lawrence Mar 23, 2022 Award Lecture Highlights Tumor Evolution Through Liquid Biopsy Leah Lawrence Mar 23, …
Landing page
… and expression signature development, lung cancer genetics, tumor-associated immunosuppression mechanisms, proteogenomic … World Health Organization (WHO) classification of Thoracic Tumors. She is an Editorial Board member and author of the … of lung cancer in screening programs. In the field of circulating biomarkers, she has a demonstrated record of …
Landing page
… use in patients with platinum-sensitive SCLC Pretreatment ctDNA as a prognostic marker in stage IIIA NSCLC Surgery for …